IP Library Patent Application 10561235
Patent Application
App. No. 10/561,235

Immunogenic Compositions Comprising Multiple Gonococcal Antigens

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/561,235
Abstract

N. gonorrhoeae is a bacterial pathogen which causes diseases including gonorrhoea, urethritis, cervicitis and pelvic inflammatory disease. In addition, like other inflammatory SYDs, infection is believed to enhance HIV transmission. Within the many proteins of the gonococcal *enome, six have been found to be particularly suitable for immunisation purposes, particularly', when used in combinations. The invention therefore provides a composition comprising two or more of the following antigens: ( 1 ) OmpA; ( 2 ) OmpH; ( 3 ) PPIase; ( 4 ) ngs 41 ; (5) ngsl 17 ; and ( 6 )', App.

Claims (22)

1 . A composition comprising two or more of the following gonococcal antigens: (1) OmpA; (2) OmpH; (3) PPIase; (4) ngs41; (5) ngs117; and (6) App.

2 . The composition of claim 1 , wherein the OmpA protein comprises an amino acid sequence:

(a) having 70% or more identity to SEQ ID : 2; and/or (b) which is a fragment of at least 10 consecutive amino acids of SEQ ID : 2.

3 . The composition of claim 1 , wherein the OmpH protein comprises an amino acid sequence:

(a) having 70% or more identity to SEQ ID : 3; and/or (b) which is a fragment of at least 10 consecutive amino acids of SEQ ID : 3.

4 . The composition of claim 1 , wherein the PPIase protein comprises an amino acid sequence:

(a) having 70% or more identity to SEQ ID : 4; and/or (b) which is a fragment of at least 10 consecutive amino acids of SEQ ID : 4.

5 . The composition of claim 1 , wherein the Ngs41 protein comprises an amino acid sequence:

(a) having 70% or more identity to SEQ ID : 5; and/or (b) which is a fragment of at least 10 consecutive amino acids of SEQ ID : 5.

6 . The composition of claim 1 , wherein the Ngs117 protein comprises an amino acid sequence:

(a) having 70% or more identity to SEQ ID : 6; and/or (b) which is a fragment of at least 10 consecutive amino acids of SEQ ID : 6.

7 . The composition of claim 1 , wherein the App protein comprises an amino acid sequence:

(a) having 70% or more identity to SEQ ID : 7; and/or (b) which is a fragment of at least 10 consecutive amino acids of SEQ ID : 7.

8 . A hybrid polypeptide of formula NH 2 —A—{—X—L—} n —B—COOH, wherein: each X is an amino acid sequence as defined in any one of claims 2 to 7 ; L is an optional linker amino acid sequence; A is an optional N terminal amino acid sequence; B is an optional C terminal amino acid sequence;

and n is 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 14 or 15.

9 . Nucleic acid encoding the hybrid polypeptide of claim 8 .

10 . A lipidated gonococcal OmpA protein.

11 . A lipidated gonococcal PPIase protein.

12 . A dimeric gonococcal OmpH protein.

13 . A dimeric gonococcal PPIase protein.

14 . A gonococcus strain, wherein one or more of the following gonococcal antigens is knocked out:

(1) OmpA; (2) OmpH; (3) PPIase; (4) ngs41; (5) ngs117; and (6) App.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2008
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: NOVARTIS AG
Reel/Frame 021615/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2006
From: SERINO, LAURA; LEUZZI, ROSANNA; FONTANA, MARIA RITA; MONACI, ELISABETTA; PIZZA, MARIAGRAZIA
To: NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.
Reel/Frame 018561/0717 →